1. Home
  2. ILMN vs ROL Comparison

ILMN vs ROL Comparison

Compare ILMN & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • ROL
  • Stock Information
  • Founded
  • ILMN 1998
  • ROL 1948
  • Country
  • ILMN United States
  • ROL United States
  • Employees
  • ILMN N/A
  • ROL N/A
  • Industry
  • ILMN Medical Specialities
  • ROL Diversified Commercial Services
  • Sector
  • ILMN Health Care
  • ROL Finance
  • Exchange
  • ILMN Nasdaq
  • ROL Nasdaq
  • Market Cap
  • ILMN 13.1B
  • ROL 27.6B
  • IPO Year
  • ILMN 2000
  • ROL N/A
  • Fundamental
  • Price
  • ILMN $100.80
  • ROL $56.44
  • Analyst Decision
  • ILMN Buy
  • ROL Buy
  • Analyst Count
  • ILMN 16
  • ROL 8
  • Target Price
  • ILMN $126.88
  • ROL $58.75
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • ROL 1.7M
  • Earning Date
  • ILMN 08-05-2025
  • ROL 07-23-2025
  • Dividend Yield
  • ILMN N/A
  • ROL 1.17%
  • EPS Growth
  • ILMN N/A
  • ROL 9.41
  • EPS
  • ILMN N/A
  • ROL 0.99
  • Revenue
  • ILMN $4,337,000,000.00
  • ROL $3,462,863,000.00
  • Revenue This Year
  • ILMN N/A
  • ROL $11.84
  • Revenue Next Year
  • ILMN $3.11
  • ROL $8.58
  • P/E Ratio
  • ILMN N/A
  • ROL $57.28
  • Revenue Growth
  • ILMN N/A
  • ROL 9.46
  • 52 Week Low
  • ILMN $68.70
  • ROL $45.34
  • 52 Week High
  • ILMN $156.66
  • ROL $58.65
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 81.33
  • ROL 48.99
  • Support Level
  • ILMN $88.68
  • ROL $54.97
  • Resistance Level
  • ILMN $95.99
  • ROL $57.25
  • Average True Range (ATR)
  • ILMN 2.91
  • ROL 0.97
  • MACD
  • ILMN 0.93
  • ROL -0.10
  • Stochastic Oscillator
  • ILMN 97.37
  • ROL 55.89

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

Share on Social Networks: